About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
Liquidia Corp (LQDA): Insider Trades and Fund Holdings
In the past 12 months, Liquidia Corp insiders reported no open-market purchases and 40 sales worth $89.6M; 25 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.
- Oct 14, 2026NewsCompany reported: Signed a material agreement
- Oct 12, 2026Insider saleCEO Roger Jeffs sold $932,549 under a 10b5-1 plan
- Oct 12, 2026Insider saleCFO Michael Kaseta sold $539,354 under a 10b5-1 plan
- Oct 12, 2026Insider saleGeneral Counsel Russell Schundler sold $389,948 under a 10b5-1 plan
- Oct 12, 2026Insider saleChief Medical Officer Rajeev Saggar sold $262,529 under a 10b5-1 plan
- Oct 12, 2026Insider saleChief Commercial Officer Scott Moomaw sold $252,418 under a 10b5-1 plan
- Oct 12, 2026Insider saleChief Business Officer Jason Adair sold $207,932 under a 10b5-1 plan
- Oct 12, 2026Insider saleCAO Dana Boyle sold $167,804 under a 10b5-1 plan
- Oct 12, 2026Insider saleChief Human Resource Officer Sarah Krepp sold $149,378 under a 10b5-1 plan
- Oct 12, 2026Insider saleChief Development Officer Sanjeev Khindri sold $31,356 under a 10b5-1 plan
- Oct 5, 2026Insider saleDirector Stephen M. Bloch sold $6.4 million
- Sep 14, 2026Insider saleDirector Raman Singh sold $560,243
- Sep 14, 2026Planned saleRAMANDEEP SINGH (director) filed notice to sell about $560,243 around Sep 14, 2026
- Sep 11, 2026Insider saleDirector Raman Singh sold $619,210
- Sep 11, 2026Planned saleRAMANDEEP SINGH (director) filed notice to sell about $619,210 around Sep 11, 2026
- Sep 1, 2026Insider saleChief Human Resource Officer Sarah Krepp sold $18,566 under a 10b5-1 plan
- Aug 21, 2026Insider saleChief Business Officer Jason Adair sold $5.1 million under a 10b5-1 plan
- Aug 21, 2026Planned saleJASON ADAIR (officer) filed notice to sell about $5.2 million around Aug 21, 2026
- Aug 20, 2026Insider saleDirector Katherine Rielly-Gauvin sold $1.3 million under a 10b5-1 plan
- Aug 19, 2026Insider saleDirector Katherine Rielly-Gauvin sold $2.8 million under a 10b5-1 plan
- Aug 19, 2026Insider saleChief Medical Officer Rajeev Saggar sold $3.7 million
- Aug 19, 2026Planned saleKatherine T. Rielly-Gauvin (director) filed notice to sell about $4.1 million around Aug 19, 2026
- Aug 19, 2026Planned saleRAJEEV SAGGAR (officer) filed notice to sell about $3.7 million around Aug 19, 2026
- Aug 17, 2026Insider saleChief Medical Officer Rajeev Saggar sold $2.3 million
- Aug 17, 2026Planned saleRAJEEV SAGGAR (officer) filed notice to sell about $2.3 million around Aug 17, 2026
- Jul 27, 2026Insider saleCAO Dana Boyle sold $140,048 under a 10b5-1 plan
- Jul 27, 2026Insider saleChief Business Officer Jason Adair sold $60,221 under a 10b5-1 plan
- Jul 23, 2026Insider saleDirector Stephen M. Bloch sold $8.9 million
- Jul 22, 2026Insider saleDirector Stephen M. Bloch sold $8.8 million
- Jul 21, 2026Insider saleDirector Stephen M. Bloch sold $6 million
- Jul 20, 2026Insider saleDirector Stephen M. Bloch sold $286,068
- Jul 13, 2026Insider saleCEO Roger Jeffs sold $2.5 million under a 10b5-1 plan
- Jul 13, 2026Insider saleCFO Michael Kaseta sold $1.5 million under a 10b5-1 plan
- Jul 13, 2026Insider saleGeneral Counsel Russell Schundler sold $1.1 million under a 10b5-1 plan
- Jul 13, 2026Insider saleChief Medical Officer Rajeev Saggar sold $709,816 under a 10b5-1 plan
- Jul 13, 2026Insider saleChief Commercial Officer Scott Moomaw sold $682,141 under a 10b5-1 plan
- Jul 13, 2026Insider saleCAO Dana Boyle sold $643,740 under a 10b5-1 plan
- Jul 13, 2026Insider saleChief Human Resource Officer Sarah Krepp sold $562,361 under a 10b5-1 plan
- Jul 13, 2026Insider saleChief Business Officer Jason Adair sold $562,289 under a 10b5-1 plan
- Jul 13, 2026Insider saleChief Development Officer Sanjeev Khindri sold $84,741 under a 10b5-1 plan
Showing the latest 40 of 48 events.
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 13, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 13 | Roger JeffsCEO | ▼ SELL10b5-1 | $933K |
| Oct 13 | Michael KasetaCFO | ▼ SELL10b5-1 | $539K |
| Oct 13 | Russell SchundlerGeneral Counsel | ▼ SELL10b5-1 | $390K |
| Oct 13 | Rajeev SaggarChief Medical Officer | ▼ SELL10b5-1 | $263K |
| Oct 13 | Scott MoomawChief Commercial Officer | ▼ SELL10b5-1 | $252K |
| Oct 13 | Jason AdairChief Business Officer | ▼ SELL10b5-1 | $208K |
| Oct 13 | Dana BoyleCAO | ▼ SELL10b5-1 | $168K |
| Oct 13 | Sarah KreppChief Human Resource Officer | ▼ SELL10b5-1 | $149K |
| Oct 13 | Sanjeev KhindriChief Development Officer | ▼ SELL10b5-1 | $31K |
| Oct 7 | Stephen M. BlochDirector | ▼ SELL | $6.39M |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Roger Jeffs | CEO | 0 | $0 | 2 | $3.45M |
| Michael Kaseta | CFO | 0 | $0 | 2 | $2.00M |
| Russell Schundler | General Counsel | 0 | $0 | 2 | $1.44M |
| Rajeev Saggar | Chief Medical Officer | 0 | $0 | 4 | $6.94M |
| Scott Moomaw | Chief Commercial Officer | 0 | $0 | 2 | $935K |
| Jason Adair | Chief Business Officer | 0 | $0 | 4 | $5.92M |
| Dana Boyle | CAO | 0 | $0 | 3 | $952K |
| Sarah Krepp | Chief Human Resource Officer | 0 | $0 | 4 | $2.48M |
Buybacks and executive pay
| Year | CEO pay reported | CEO pay "actually paid" | Value of $100 invested |
|---|---|---|---|
| 2025 | $7.71M | $34.9M | n/a |
| 2024 | $6.75M | $6.24M | n/a |
| 2023 | $4.89M | $15.5M | n/a |
From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.
A All 40 insider trades reported on time. How it is graded
Tracked funds that report LQDA
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 232,353 | $18.5M | ▲ +2768.6% |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →